CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'Stinne Ravn Greisen, Malene Hvid, Tue Kruse Rasmussen et al.|Arthritis Research & Therapy|2014Cited by 81